Search research articles
Contact Us
Filters
Showing results (161-170 of 174) with videos related to
Page
of 18
Sort By:
Cell Death & Disease
|
August 14, 2025
Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiation
Hans Felix Staehle, Christoph Koellerer, Anne Marie Staehle, et al.
Blood
|
August 24, 2011
TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms
Angela G Fleischman, Karl J Aichberger, Samuel B Luty, et al.
The Journal of Experimental Medicine
|
January 11, 2012
A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2
Kai B Kaufmann, Albert Gründer, Tobias Hadlich, et al.
Leukemia & Lymphoma
|
January 8, 2015
Phase I dose escalation study of lestaurtinib in patients with myelofibrosis
Elizabeth O Hexner, John Mascarenhas, Josef Prchal, et al.
Cancers
|
August 27, 2021
Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry
Judith Gecht, Ioannis Tsoukakis, Kim Kricheldorf, et al.
Blood Advances
|
August 28, 2023
GPRC5C drives branched-chain amino acid metabolism in leukemogenesis
Yu Wei Zhang, Talia Velasco-Hernandez, Julian Mess, et al.
Cancer Research
|
June 17, 2024
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment
Dominik Schmidt, Cornelia Endres, Rouven Hoefflin, et al.
Leukemia
|
July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
J V Jovanovic, A Ivey, A M Vannucchi, et al.
The Journal of Clinical Investigation
|
June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice
Nana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2012
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs
Robyn M Emanuel, Amylou C Dueck, Holly L Geyer, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 174) with videos related to
Sort By:
Page
of 18
Cell Death & Disease
|
August 14, 2025
Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiation
Hans Felix Staehle, Christoph Koellerer, Anne Marie Staehle, et al.
Blood
|
August 24, 2011
TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms
Angela G Fleischman, Karl J Aichberger, Samuel B Luty, et al.
The Journal of Experimental Medicine
|
January 11, 2012
A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2
Kai B Kaufmann, Albert Gründer, Tobias Hadlich, et al.
Leukemia & Lymphoma
|
January 8, 2015
Phase I dose escalation study of lestaurtinib in patients with myelofibrosis
Elizabeth O Hexner, John Mascarenhas, Josef Prchal, et al.
Cancers
|
August 27, 2021
Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry
Judith Gecht, Ioannis Tsoukakis, Kim Kricheldorf, et al.
Blood Advances
|
August 28, 2023
GPRC5C drives branched-chain amino acid metabolism in leukemogenesis
Yu Wei Zhang, Talia Velasco-Hernandez, Julian Mess, et al.
Cancer Research
|
June 17, 2024
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment
Dominik Schmidt, Cornelia Endres, Rouven Hoefflin, et al.
Leukemia
|
July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
J V Jovanovic, A Ivey, A M Vannucchi, et al.
The Journal of Clinical Investigation
|
June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice
Nana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2012
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs
Robyn M Emanuel, Amylou C Dueck, Holly L Geyer, et al.
Page
of 18